medline.ch Gastroenterologie Oesophagus Neoplasie

	Can Esophagectomy be Safely Avoided After Clinical Complete Response in Esophageal Squamous Cell Carcinoma? Response Assessment, Active Surveillance, and Salvage in the Immunotherapy Era. Curr Oncol Rep Sagawa T, Hirakawa M, Nagashima H, Fujikawa K. PMID: 42975733 [PubMed - indexed for MEDLINE]
	Oncologic efficacy and safety of stereotactic body radiotherapy for oligometastatic non-small cell lung cancer: a systemic meta-analysis. Clin Exp Metastasis Jeong JU, Yoo GS, Lee JH, Chan Ahn Y, Rim CH, Chie EK, Chang AR, Korean Cancer Association Oligometastasis Working Group. PMID: 42975717 [PubMed - indexed for MEDLINE]
	Coronary artery calcification is not associated with survival in advanced gastric and gastroesophageal junction cancer: a secondary analysis of the EXPAND trial. J Cancer Res Clin Oncol Meyer HJ, Dermendzhiev T, Jacobs PP, Romeo D, Stocker G, Denecke T, Lordick F, Hacker UT. PMID: 42975671 [PubMed - indexed for MEDLINE]
	Leptomeningeal carcinomatosis arising from esophageal cancer: a systematic review of the literature. Dis Esophagus Mylonakis A, Stylios D, Tsilimigras D, Charalampopoulos G, Kotsantis I, Liontos M, Georgakopoulos I, Schizas D. PMID: 42974869 [PubMed - indexed for MEDLINE]
	Efficacy and safety analysis of consolidation immunotherapy following definitive concurrent chemoradiotherapy for locally advanced esophageal squamous cell carcinoma. Front Immunol Liu W, Zhu Q, Xu S, Chen J, Wang D, Wu T, Shen J, Zhu Y, Chen Z, Liu Y, Wang G, Wu C, Wang Y. PMID: 42973545 [PubMed - indexed for MEDLINE]
	Are non-cancer diagnoses missed opportunities in diagnosing cancer? Observational case-control studies. Br J Gen Pract Price S, Abel GA, Black G, Friedemann Smith C, Hamilton W, King A, Laity G, Lavu D, Moore SF, Mounce LTA, Nansubuga E, Nicholson BD, Ramasawmy M, Robles L, Scott S, Spencer A, Walter FM, Wiering B, Neal R. PMID: 42971713 [PubMed - as supplied by publisher]
	High-dose reirradiation of in-field recurrence lung cancer in the THOrax (RETHO): toxicity analysis of a prospective trial. Int J Radiat Oncol Biol Phys Duijm DM, Cammareri E, Granton DPV, Schillemans W, Petit DS, Belderbos DJ, van Werkhoven DE, Cornelissen DR, Knegjens JL, Nuyttens DJJ. PMID: 42971440 [PubMed - as supplied by publisher]
	Salvage esophagectomy versus photodynamic therapy for localized residual or recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy or radiotherapy: a single-center comparative study. J Gastroenterol Ujiie N, Sato C, Taniyama Y, Okamoto H, Ozawa Y, Ishida H, Unno M, Kamei T. PMID: 42970107 [PubMed - as supplied by publisher]
	Definitive Chemoradiotherapy for Cervical Esophageal Squamous Cell Carcinoma: A Single-institution Retrospective Study. Cancer Diagn Progn Katano A, Yamashita H. PMID: 42968802 [PubMed]
	Evaluation of the efficacy and safety of different cycles of neoadjuvant chemotherapy combined with immunotherapy in locally advanced esophageal squamous cell carcinoma: a multi-center, real-world study. World J Surg Oncol Lv H, Wang Z, Su C, Wang H, Chen B, Gai C, Liu Y, Ding W, Wang M, Sun K, Zhang F, Zhu Y, Li Z, Tian Z. PMID: 42968170 [PubMed - indexed for MEDLINE]
	Survival outcomes of treatment strategies for cTanyN3M0 esophageal cancer: A nationwide population-based study. Radiother Oncol Hafkamp CJH, Geijsen ED, van Laarhoven HWM, Derks S, Bennink RJ, Verhoeven RHA, Meijer SL, Gisbertz SS, van Berge Henegouwen MI, Olthof PB, van der Veen A, van Rossum PSN. PMID: 42967538 [PubMed - as supplied by publisher]
	Elevated UBE2L6 Expression Predicts Poor Prognosis and Is Associated With Fatty Acid Metabolic Remodeling in Esophageal Cancer. Mol Carcinog Yao MJ, Wen ML, Ma MJ, Zhang MR, Hu MX, Zhao MC, Mu MB. PMID: 42967324 [PubMed - as supplied by publisher]
	Integrative Genetic and Functional Analysis Identifies the Asparagine-SLC38A2 Axis in Esophageal Squamous Cell Carcinoma. Mol Carcinog Ma J, Wu Y, Luo Y, Feng J, Guo W, Chang J. PMID: 42967322 [PubMed - as supplied by publisher]
	Histology-dependent coupling of TERT to the proliferation programme statistically accounts for much of the between-cohort heterogeneity in DNMT3B-TERT co-expression in oesophageal carcinoma: a 27-cohort meta-analysis and pan-cancer re-analysis. Funct Integr Genomics Khorrami M, Parvaresh E, Asadi J, Tatar M. PMID: 42965673 [PubMed - indexed for MEDLINE]
	The synergistic potential of combining PD-1/PD-L1 inhibitors with conventional therapies in esophageal squamous cell carcinoma. Front Pharmacol Li R, Heng Z, Cheng X. PMID: 42964272 [PubMed]
	Primary Liver Cancer and Other Malignancies in Alcohol Use Disorder and Alcohol-Associated Liver Disease. Liver Int Pizarro G, Alcayaga B, Rama K, González-Montero J, Arrese M, Arab JP, Díaz LA. PMID: 42963959 [PubMed - indexed for MEDLINE]
	Cancer in Seychelles: A Population-Based Study on Incidence, Trends and Stage at Diagnosis (2005-2024). Int J Cancer Finesse A, Mondon J, Shroff E, Gedeon J, Louange M, Parkin DM. PMID: 42963954 [PubMed - as supplied by publisher]
	Protocol for a multicenter prospective phase II trial of adjuvant tislelizumab combined with S-1 in subjects with residual primary lesions and node-negative esophageal squamous cell carcinoma (PPIO-008). Future Oncol Wang YJ, Chen X, Xie XF, Li CF, Bao T, He XD, Li KK, Pu XS, He Y, Guo W. PMID: 42961934 [PubMed - as supplied by publisher]
	ASO Visual Abstract:Â Prognostic Impact of Bulky Lymph Node Metastasis in Thoracic Esophageal Squamous Cell Carcinoma: A Multicenter Cohort Study. Ann Surg Oncol Zhang G, Zhang K, Yuan C, Zhang Y, Mu T, Jiao J, Qiu L, Pan X, Zhao J, Li Z, Li X. PMID: 42961695 [PubMed - as supplied by publisher]
	Cancer-associated fibroblasts: origins, functional heterogeneity and therapeutic potential. Signal Transduct Target Ther Zhou L, Tang M, Wang K, Wang N, Zhang J, Liu K, Li X, Dong Z. PMID: 42957652 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 40025

Seite 1 von 2002

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung